Ryan Thomas is the chair of the firm’s Private Equity Team and co-chair of the Healthcare Private Equity Team. As mergers and acquisitions (M&A) and securities counsel to numerous national companies and private equity firms, Ryan Thomas has closed over $60 billion in M&A transactions, and approximately $80 billion in overall transactions, including both the largest domestic LBO, and the largest private equity-backed IPO at the time. Ryan’s practice focuses on public and private companies within the healthcare, media, retail, government services, life sciences and technology industries, among others. Ryan also advises management, boards and special committees on shareholder activism, corporate governance and public company disclosure matters.
Ryan’s practice involves:
Ryan has been recognized by various leading outlets, such as Chambers USA and The M&A Advisor, for his work in the M&A and private equity space. In 2021 alone, The M&A Advisor named two of Ryan’s deals as finalists in eight categories for the 2021 M&A Advisor Awards. Over the past few years, several transactions have been named as finalists in multiple categories including:
Ryan is active in the leadership of the ABA’s M&A and Business Law Committees, serving as editor of the Deal Points publication and the executive editor for M&A content of Business Law Today. He has been extensively quoted and published on M&A matters and high profile deals in leading national media such as The Wall Street Journal Pro Private Equity, The Business Lawyer, The Corporate Board, Executive Counsel, Marketwatch.com, Los Angeles Times, TheStreet.com, GlobeSt.com, Associate Press, Bloomberg News and others.
Association for Corporate Growth, Tennessee Chapter — Board Member
American Health Law Association (AHLA)
American Bar Association — Business Law and M&A Committees
Conducted due diligence and regulatory analysis for a Medicare Advantage plan in connection with multiple transactions involving multispecialty physician practice groups, management service organizations (MSOs), and accountable care organizations. (ACOs)
Representation of TT Capital Partners, a value-add healthcare investor that provides capital, expertise and insight to healthcare technology and services companies that have the potential to become market leaders, in its investment in InHome Therapy, the nation’s first Home Therapy as a Service (HTaaS) solution, for 22 million.
Representation of Prairie Capital’s portfolio company Family Allergy & Asthma, an allergy medical practice headquartered in Louisville, KY, in its Physician Practice Management transaction with Asthma and Allergy Associates of Florida, an allergy and asthma medical practice in Flordia. Terms of the transaction were not disclosed.
Representation of Advanced Dermatology and Cosmetic Surgery, one of the country’s leading dermatology practices, in its acquisition of Esterson Dermatology, a dermatology practice. Terms of the transaction were not disclosed.
Representation of The Peach Truck, a direct-to-consumer seller of peaches in the world, in its sale to International Farming, a privately owned institutional investment manager at the center of the world’s food ecosystem. Terms of the transaction were not disclosed.
Representation of Arcline Investment Management’s portfolio company Standard Elevator Systems, which manufactures and provides products and solutions for elevators, escalators and moving walks, in its acquisition of McIntosh Industries, LLC, a company specializing in rebuilding, repair and service of elevator motors and machines. Terms of the transaction were not disclosed.
Representation of Northlane Capital Partners, a middle market private equity firm, in its acquisition of SAI MedPartners, a leading consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries. Terms of the transaction were not disclosed.
Representation of Arcline Investment Management’s portfolio company Fairbanks Morse, which builds, maintains, and services naval power and propulsion systems, in its acquisition of Research Tool & Die, a privately owned manufacturer of marine electrical-systems hardware. Terms of the transaction were not disclosed.
Representation of SENTA Partners, a physician practice management company, in its acquisition of all non-clinical assets of Allergy, Asthma & Immunology Associates of South Texas, a well known ENT practice in the state. Terms of the transaction were not disclosed.
Chambers USA — Corporate/M&A (2019-2022), Recognized Practitioner (2017-2018)
M&A Advisor — Finalist (2021):
Who’s Who Legal — Corporate: Corporate Governance (2018-2021); Corporate: Mergers & Acquisitions (2018-2021)
Acritas Stars — Independently Rated Lawyer (2019-2020)
IFLR1000 — Notable Practitioner (2019-2021)
M&A Advisor — Winner (2019):
M&A Advisor — Finalist (2019):
M&A Advisor — “M&A Deal of the Year” Finalist (2015)
M&A Advisor — “40 Under 40” Finalist (2012)
M&A Advisor — “M&A Deal of the Year” (2012)
Mid-South Super Lawyers “Rising Star” (2011-2014)
Vanderbilt Journal of Transnational Law — Editor
Phi Beta Kappa